256 related articles for article (PubMed ID: 27084396)
1. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review.
Ahlin F; Arfvidsson J; Vargas KG; Stojkovic S; Huber K; Wojta J
Vascul Pharmacol; 2016 Jun; 81():15-21. PubMed ID: 27084396
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: A novel approach to disease diagnosis of stable CAD and acute coronary syndrome.
Parizadeh SM; Ferns GA; Ghandehari M; Hassanian SM; Ghayour-Mobarhan M; Parizadeh SMR; Avan A
J Cell Physiol; 2018 Sep; 233(9):6418-6424. PubMed ID: 29215707
[TBL] [Abstract][Full Text] [Related]
3. Artificial neural network modeling enhances risk stratification and can reduce downstream testing for patients with suspected acute coronary syndromes, negative cardiac biomarkers, and normal ECGs.
Isma'eel HA; Cremer PC; Khalaf S; Almedawar MM; Elhajj IH; Sakr GE; Jaber WA
Int J Cardiovasc Imaging; 2016 Apr; 32(4):687-96. PubMed ID: 26626458
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?
Tsounis D; Deftereos S; Bouras G; Giannopoulos G; Anatoliotakis N; Raisakis K; Kossyvakis C; Cleman MW
Curr Top Med Chem; 2013; 13(2):201-15. PubMed ID: 23470078
[TBL] [Abstract][Full Text] [Related]
5. microRNA assays for acute coronary syndromes.
Shirvani Samani O; Meder B
Diagnosis (Berl); 2016 Dec; 3(4):183-188. PubMed ID: 29536899
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
[TBL] [Abstract][Full Text] [Related]
7. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.
Ferencik M; Liu T; Mayrhofer T; Puchner SB; Lu MT; Maurovich-Horvat P; Pope JH; Truong QA; Udelson JE; Peacock WF; White CS; Woodard PK; Fleg JL; Nagurney JT; Januzzi JL; Hoffmann U
JACC Cardiovasc Imaging; 2015 Nov; 8(11):1272-1281. PubMed ID: 26476506
[TBL] [Abstract][Full Text] [Related]
8. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.
Deddens JC; Colijn JM; Oerlemans MI; Pasterkamp G; Chamuleau SA; Doevendans PA; Sluijter JP
J Cardiovasc Transl Res; 2013 Dec; 6(6):884-98. PubMed ID: 23897095
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs: novel biomarkers of acute coronary syndrome?
Pleister A; Selemon H; Elton SM; Elton TS
Biomark Med; 2013 Apr; 7(2):287-305. PubMed ID: 23547823
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease.
Stojkovic S; Nossent AY; Haller P; Jäger B; Vargas KG; Wojta J; Huber K
Thromb Haemost; 2019 Oct; 119(10):1563-1572. PubMed ID: 31421643
[TBL] [Abstract][Full Text] [Related]
12. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
[TBL] [Abstract][Full Text] [Related]
13. Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.
Šatrauskienė A; Navickas R; Laucevičius A; Huber HJ
BMC Cardiovasc Disord; 2017 Jun; 17(1):173. PubMed ID: 28666417
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
Searle J; Danne O; Müller C; Mockel M
Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in acute coronary artery disease.
Freynhofer MK; Tajsić M; Wojta J; Huber K
Wien Med Wochenschr; 2012 Nov; 162(21-22):489-98. PubMed ID: 23143510
[TBL] [Abstract][Full Text] [Related]
16. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs.
Oerlemans MI; Mosterd A; Dekker MS; de Vrey EA; van Mil A; Pasterkamp G; Doevendans PA; Hoes AW; Sluijter JP
EMBO Mol Med; 2012 Nov; 4(11):1176-85. PubMed ID: 23023917
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.
Garg P; Morris P; Fazlanie AL; Vijayan S; Dancso B; Dastidar AG; Plein S; Mueller C; Haaf P
Intern Emerg Med; 2017 Mar; 12(2):147-155. PubMed ID: 28188579
[TBL] [Abstract][Full Text] [Related]
18. LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome.
Field PA; Vasan RS
Clin Pharmacol Ther; 2018 Aug; 104(2):232-234. PubMed ID: 30004115
[TBL] [Abstract][Full Text] [Related]
19. Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician.
Hickman PE; Lindahl B; Cullen L; Koerbin G; Tate J; Potter JM
Crit Rev Clin Lab Sci; 2015 Feb; 52(1):28-44. PubMed ID: 25397345
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Mean Platelet Volume to Predict Significant Coronary Artery Disease in Patients With Non-ST-Elevation Acute Coronary Syndromes.
Taskesen T; Sekhon H; Wroblewski I; Goldfarb M; Ahmad MB; Nguyen QT; Fughhi IA; Gidron A; Dadkhah S
Am J Cardiol; 2017 Jan; 119(2):192-196. PubMed ID: 27814786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]